A Jeff Bezos-backed startup just inked a deal with $84 billion biotech Gilead to make drugs for a troubling and increasingly common disease Posted by Genevieve Klien in biotech/medical Apr 162019 Insitro and Gilead are teaming up to create drugs to treat a liver disease affecting millions. The startup is backed by Jeff Bezos, Andreessen Horowitz, and GV. Read more